153 related articles for article (PubMed ID: 9174621)
1. Partial purification and characterization of a tumor necrosis factor-alpha converting activity.
Robache-Gallea S; Bruneau JM; Robbe H; Morand V; Capdevila C; Bhatnagar N; Chouaib S; Roman-Roman S
Eur J Immunol; 1997 May; 27(5):1275-82. PubMed ID: 9174621
[TBL] [Abstract][Full Text] [Related]
2. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.
Gallea-Robache S; Morand V; Millet S; Bruneau JM; Bhatnagar N; Chouaib S; Roman-Roman S
Cytokine; 1997 May; 9(5):340-6. PubMed ID: 9195133
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25.
Cerretti DP; Poindexter K; Castner BJ; Means G; Copeland NG; Gilbert DJ; Jenkins NA; Black RA; Nelson N
Cytokine; 1999 Aug; 11(8):541-51. PubMed ID: 10433800
[TBL] [Abstract][Full Text] [Related]
4. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases.
Rosendahl MS; Ko SC; Long DL; Brewer MT; Rosenzweig B; Hedl E; Anderson L; Pyle SM; Moreland J; Meyers MA; Kohno T; Lyons D; Lichenstein HS
J Biol Chem; 1997 Sep; 272(39):24588-93. PubMed ID: 9305925
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
Amour A; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Stephens PE; Shelley C; Hutton M; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 1998 Sep; 435(1):39-44. PubMed ID: 9755855
[TBL] [Abstract][Full Text] [Related]
7. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity.
Mohan MJ; Seaton T; Mitchell J; Howe A; Blackburn K; Burkhart W; Moyer M; Patel I; Waitt GM; Becherer JD; Moss ML; Milla ME
Biochemistry; 2002 Jul; 41(30):9462-9. PubMed ID: 12135369
[TBL] [Abstract][Full Text] [Related]
8. Structural features and biochemical properties of TNF-alpha converting enzyme (TACE).
Moss ML; Jin SL; Becherer JD; Bickett DM; Burkhart W; Chen WJ; Hassler D; Leesnitzer MT; McGeehan G; Milla M; Moyer M; Rocque W; Seaton T; Schoenen F; Warner J; Willard D
J Neuroimmunol; 1997 Feb; 72(2):127-9. PubMed ID: 9042103
[TBL] [Abstract][Full Text] [Related]
9. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.
Black RA; Durie FH; Otten-Evans C; Miller R; Slack JL; Lynch DH; Castner B; Mohler KM; Gerhart M; Johnson RS; Itoh Y; Okada Y; Nagase H
Biochem Biophys Res Commun; 1996 Aug; 225(2):400-5. PubMed ID: 8753775
[TBL] [Abstract][Full Text] [Related]
10. Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form.
Itai T; Tanaka M; Nagata S
Eur J Biochem; 2001 Apr; 268(7):2074-82. PubMed ID: 11277930
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion.
Solomon KA; Pesti N; Wu G; Newton RC
J Immunol; 1999 Oct; 163(8):4105-8. PubMed ID: 10510344
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis.
Zhao J; Chen H; Peschon JJ; Shi W; Zhang Y; Frank SJ; Warburton D
Dev Biol; 2001 Apr; 232(1):204-18. PubMed ID: 11254358
[TBL] [Abstract][Full Text] [Related]
14. Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mapping.
Lambert MH; Blackburn RK; Seaton TD; Kassel DB; Kinder DS; Leesnitzer MA; Bickett DM; Warner JR; Andersen MW; Badiang JG; Cowan DJ; Gaul MD; Petrov KG; Rabinowitz MH; Wiethe RW; Becherer JD; McDougald DL; Musso DL; Andrews RC; Moss ML
Comb Chem High Throughput Screen; 2005 Jun; 8(4):327-39. PubMed ID: 16101009
[TBL] [Abstract][Full Text] [Related]
15. TNF-Induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase.
Dri P; Gasparini C; Menegazzi R; Cramer R; Albéri L; Presani G; Garbisa S; Patriarca P
J Immunol; 2000 Aug; 165(4):2165-72. PubMed ID: 10925303
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.
Cherney RJ; Duan JJ; Voss ME; Chen L; Wang L; Meyer DT; Wasserman ZR; Hardman KD; Liu RQ; Covington MB; Qian M; Mandlekar S; Christ DD; Trzaskos JM; Newton RC; Magolda RL; Wexler RR; Decicco CP
J Med Chem; 2003 May; 46(10):1811-23. PubMed ID: 12723945
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.
Williams LM; Gibbons DL; Gearing A; Maini RN; Feldmann M; Brennan FM
J Clin Invest; 1996 Jun; 97(12):2833-41. PubMed ID: 8675695
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.
Reddy P; Slack JL; Davis R; Cerretti DP; Kozlosky CJ; Blanton RA; Shows D; Peschon JJ; Black RA
J Biol Chem; 2000 May; 275(19):14608-14. PubMed ID: 10799547
[TBL] [Abstract][Full Text] [Related]
19. Processing of tumour necrosis factor-alpha precursor by metalloproteinases.
Gearing AJ; Beckett P; Christodoulou M; Churchill M; Clements J; Davidson AH; Drummond AH; Galloway WA; Gilbert R; Gordon JL
Nature; 1994 Aug; 370(6490):555-7. PubMed ID: 8052310
[TBL] [Abstract][Full Text] [Related]
20. Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.
Holms J; Mast K; Marcotte P; Elmore I; Li J; Pease L; Glaser K; Morgan D; Michaelides M; Davidsen S
Bioorg Med Chem Lett; 2001 Nov; 11(22):2907-10. PubMed ID: 11677124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
